HM Pharma SRL
1.1 FTEThe score of HM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +151 % Total assets +283 % Headcount (avg FTE) -8 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HM Pharma's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 67,980 € | ||||
| Equity | 354,554 € | ||||
| Cash | 181,683 € | ||||
| EBITDA | 109,093 € | ||||
| Total assets | €1.25m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 28 Sep 2026
- Year ended 31 Mar 2025filed on 14 Oct 2025
- Year ended 31 Mar 2024filed on 15 Oct 2024
- Year ended 31 Mar 2023filed on 09 Oct 2023
- Year ended 31 Mar 2022filed on 10 Oct 2022
HM Pharma's financial analysis
- Solvency28.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HM Pharma
HM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.423.931
- VAT number
- BE0765423931
- Peppol
- Registered · 0208:0765423931 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Mar 2021
- Registered office
- 8740 Pittem
- Size
- Micro · 1.1 FTE
- Latest accounts
- 2026 · filed on 28 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
HM Pharma (SRL) has been based in Pittem since 2021, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 67,980 € and equity of 354,554 €; its revenue is not published. With 1.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 28.3%, below the median of its sector (44.0%).
Companies similar to HM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Vanlaer Retail sale of pharmaceutical products Hasselt · balance sheet €1.25m
- Alba2RO Retail sale of pharmaceutical products Gembloux · balance sheet €1.25m
- Ritzen Anouk Retail sale of pharmaceutical products Keerbergen · balance sheet €1.25m
- EASI Retail sale of pharmaceutical products Ciney · balance sheet €1.24m
- Benjamin BENEUX Retail sale of pharmaceutical products Ans · balance sheet €1.28m
Frequently asked questions about HM Pharma
What is the revenue of HM Pharma?
HM Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of HM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0765423931 for HM Pharma, if the company is VAT-registered. Its company number (CBE) is 0765.423.931.
Where is the registered office of HM Pharma?
According to the CBE register, the registered office of HM Pharma is in 8740 Pittem.
What is the equity of HM Pharma?
At the close of the 2026 financial year, the equity of HM Pharma amounts to 354,554 €, a solvency of 28.3% of total assets.
How many people work at HM Pharma?
1.1 full-time equivalents on average according to the 2026 social balance sheet.
Who manages HM Pharma?
The register lists 2 active mandates at HM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →